These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 29784572)

  • 1. The burden of familial chylomicronemia syndrome: Results from the global IN-FOCUS study.
    Davidson M; Stevenson M; Hsieh A; Ahmad Z; Roeters van Lennep J; Crowson C; Witztum JL
    J Clin Lipidol; 2018; 12(4):898-907.e2. PubMed ID: 29784572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The burden of familial chylomicronemia syndrome in Canadian patients.
    Gaudet D; Stevenson M; Komari N; Trentin G; Crowson C; Hadker N; Bernard S
    Lipids Health Dis; 2020 Jun; 19(1):120. PubMed ID: 32487261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The burden of familial chylomicronemia syndrome: interim results from the IN-FOCUS study.
    Davidson M; Stevenson M; Hsieh A; Ahmad Z; Crowson C; Witztum JL
    Expert Rev Cardiovasc Ther; 2017 May; 15(5):415-423. PubMed ID: 28338353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial Chylomicronemia Syndrome: A Clinical Guide For Endocrinologists.
    Falko JM
    Endocr Pract; 2018 Aug; 24(8):756-763. PubMed ID: 30183397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial chylomicronemia syndrome: Bringing to life dietary recommendations throughout the life span.
    Williams L; Rhodes KS; Karmally W; Welstead LA; Alexander L; Sutton L;
    J Clin Lipidol; 2018; 12(4):908-919. PubMed ID: 29804909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The burden of familial chylomicronemia syndrome from the patients' perspective.
    Gelrud A; Williams KR; Hsieh A; Gwosdow AR; Gilstrap A; Brown A
    Expert Rev Cardiovasc Ther; 2017 Nov; 15(11):879-887. PubMed ID: 28847199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of volanesorsen treatment on the burden associated with familial chylomicronemia syndrome: the results of the ReFOCUS study.
    Arca M; Hsieh A; Soran H; Rosenblit P; O'Dea L; Stevenson M
    Expert Rev Cardiovasc Ther; 2018 Jul; 16(7):537-546. PubMed ID: 29889589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial chylomicronemia syndrome: A rare but devastating autosomal recessive disorder characterized by refractory hypertriglyceridemia and recurrent pancreatitis.
    Chyzhyk V; Brown AS
    Trends Cardiovasc Med; 2020 Feb; 30(2):80-85. PubMed ID: 31003756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterizing familial chylomicronemia syndrome: Baseline data of the APPROACH study.
    Blom DJ; O'Dea L; Digenio A; Alexander VJ; Karwatowska-Prokopczuk E; Williams KR; Hemphill L; Muñiz-Grijalvo O; Santos RD; Baum S; Witztum JL
    J Clin Lipidol; 2018; 12(5):1234-1243.e5. PubMed ID: 30318066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Qualitative development of the PROMIS Profile v1.0-Familial Chylomicronemia Syndrome (FCS) 28.
    Kaiser K; Fox RS; Perschon C; Vera-Llonch M; Alonso J; Cubells L; Cella D
    Qual Life Res; 2023 Feb; 32(2):605-614. PubMed ID: 36310187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial chylomicronemia syndrome: an under-recognized cause of severe hypertriglyceridaemia.
    Baass A; Paquette M; Bernard S; Hegele RA
    J Intern Med; 2020 Apr; 287(4):340-348. PubMed ID: 31840878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced psychological distress in familial chylomicronemia syndrome after patient support group intervention.
    Wilson LM; Cross RR; Duell PB
    J Clin Lipidol; 2018; 12(1):240-242. PubMed ID: 29195809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disappearance of recurrent pancreatitis after splenectomy in familial chylomicronemia syndrome.
    Marco-Benedí V; Lamiquiz-Moneo I; Álvarez-Sala LA; Civeira F
    Atherosclerosis; 2018 Aug; 275():342-345. PubMed ID: 30015297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptoms and impacts of familial chylomicronemia syndrome: a qualitative study of the patient experience.
    Williams K; Tickler G; Valdivielso P; Alonso J; Vera-Llonch M; Cubells L; Acaster S
    Orphanet J Rare Dis; 2023 Oct; 18(1):316. PubMed ID: 37817256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial Chylomicronemia Syndrome (FCS): Recent Data on Diagnosis and Treatment.
    Gallo A; Béliard S; D'Erasmo L; Bruckert E
    Curr Atheroscler Rep; 2020 Aug; 22(11):63. PubMed ID: 32852651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic algorithm for familial chylomicronemia syndrome.
    Stroes E; Moulin P; Parhofer KG; Rebours V; Löhr JM; Averna M
    Atheroscler Suppl; 2017 Jan; 23():1-7. PubMed ID: 27998715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Building a better understanding of the burden of disease in familial chylomicronemia syndrome.
    Ahmad Z; Halter R; Stevenson M
    Expert Rev Clin Pharmacol; 2017 Jan; 10(1):1-3. PubMed ID: 27771961
    [No Abstract]   [Full Text] [Related]  

  • 18. Estimating health state utilities associated with a rare disease: familial chylomicronemia syndrome (FCS).
    Matza LS; Phillips GA; Howell TA; Ciffone N; Ahmad Z
    J Med Econ; 2020 Sep; 23(9):978-984. PubMed ID: 32479143
    [No Abstract]   [Full Text] [Related]  

  • 19. [Familial chylomicronemia syndrome: pediatric experience in Argentina].
    Araujo MB; Eiberman G; Etcheverry N; Pacheco G
    Arch Argent Pediatr; 2022 Jun; 120(3):e123-e127. PubMed ID: 35533124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of a Fat-Restricted Diet in Four Patients with Familial Chylomicronemia Syndrome: A Long-Term Follow-Up Study.
    Thajer A; Skacel G; de Gier C; Greber-Platzer S
    Children (Basel); 2021 Nov; 8(11):. PubMed ID: 34828789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.